Revised forecast
Fiscal year ending March 2027 · Interim period/full yearPrevious forecast published Announced on 13 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The first-half forecast is expected to exceed the previous forecast, owing to higher selling prices in the Resins and Chemicals segment against a backdrop of surging raw material and fuel costs, adjustments to selling prices, the occurrence of inventory valuation differences, and firm sales in the Functional Products and Machinery segments. For the full year, selling prices are expected to rise against a backdrop of surging raw material and fuel costs, while sales of pharmaceuticals are expected to remain sluggish and integration costs for high-performance urethane are expected to increase; sales of resins and chemicals, functional products and machinery are expected to remain firm.
| Item | Details |
|---|---|
| Net Sales | Interim period 235,000 / Full year 485,000 → Interim period 244,700 / Full year 518,000（Interim period 4.1 / Full year 6.8） |
| Operating profit | Interim period 5,500 / Full year 23,500 → Interim period 12,200 / Full year 26,500（Interim period 121.8 / Full year 12.8） |
| Ordinary income | Interim period 14,000 / Full year 37,500 → Interim period 20,500 / Full year 39,000（Interim period 46.4 / Full year 4） |
| Profit attributable to owners of the parent | Interim period 9,500 / Full year 24,500 → Interim period 10,500 / Full year 25,500（Interim period 10.5 / Full year 4.1） |
| Net income per share | Interim period 97.79 / Full year 252.2 → Interim period 108.07 / Full year 262.44 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Interim period/full year |
| Publication date of previous forecast | Announced on 13 May 2026 |
| Previous-period results | Interim period Net Sales ¥212,704 million and yen/sen / Operating profit ¥8,439 million and yen/sen / Ordinary income ¥16,101 million and yen/sen / Interim net income attributable to owners of the parent ¥11,086 million and yen/sen / Interim net income per share ¥114.14 million and yen/sen / Full year Net Sales ¥462,343 million and yen/sen / Operating profit ¥18,941 million and yen/sen / Ordinary income ¥37,506 million and yen/sen / Profit attributable to owners of the parent ¥23,872 million and yen/sen / Net income per share ¥245.76 million and yen/sen |
| Reason for the revision | The first-half forecast is expected to exceed the previous forecast, owing to higher selling prices in the Resins and Chemicals segment against a backdrop of surging raw material and fuel costs, adjustments to selling prices, the occurrence of inventory valuation differences, and firm sales in the Functional Products and Machinery segments. For the full year, selling prices are expected to rise against a backdrop of surging raw material and fuel costs, while sales of pharmaceuticals are expected to remain sluggish and integration costs for high-performance urethane are expected to increase; sales of resins and chemicals, functional products and machinery are expected to remain firm. |
| Dividend forecast revision | No revision (the dividend forecast remains unchanged) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The main reasons were higher selling prices in the Resins and Chemicals segment against a backdrop of surging raw material and fuel costs, adjustments to selling prices, the occurrence of inventory valuation differences, and firm sales of functional products and machinery. For the full year, sales of pharmaceuticals are expected to remain sluggish and integration costs for high-performance urethane are expected to increase, while sales of resins and chemicals, functional products and machinery are expected to remain firm.